WHO, the Global Fund, and medical malpractice in malaria treatment.
Attaran
Amir
A
Royal Institute of International Affairs, London, UK. aattaran@riia.org
Barnes
Karen I
KI
Curtis
Christopher
C
d'Alessandro
Umberto
U
Fanello
Caterina I
CI
Galinski
Mary R
MR
Kokwaro
Gilbert
G
Looareesuwan
Sornchai
S
Makanga
Michael
M
Mutabingwa
Theonest K
TK
Talisuna
Ambrose
A
Trape
Jean François
JF
Watkins
William M
WM
D000349:Africa; D000962:Antimalarials / Q000191:economics / Q000627:therapeutic use*; D037621:Artemisinins / Q000191:economics / Q000627:therapeutic use; D002648:Child; D002738:Chloroquine / Q000191:economics / Q000627:therapeutic use; D004338:Drug Combinations; D016527:Drug Costs / Q000706:statistics & numerical data; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006801:Humans; D007390:International Agencies / Q000191:economics / Q000458:organization & administration*; D008288:Malaria / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control*; D016778:Malaria, Falciparum / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control; D008318:Malpractice; D011739:Pyrimethamine / Q000191:economics / Q000627:therapeutic use; D012717:Sesquiterpenes / Q000191:economics / Q000627:therapeutic use; D013413:Sulfadoxine / Q000191:economics / Q000627:therapeutic use; D017211:Treatment Failure; D014944:World Health Organization / Q000458:organization & administration
D000962:Antimalarials; D037621:Artemisinins; D004338:Drug Combinations; D012717:Sesquiterpenes; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D002738:Chloroquine; C031327:artemisinin; D011739:Pyrimethamine